Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.19.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Operating Expenses:    
Research and development $ 3,085,317 $ 964,164
General and administrative 1,439,623 838,269
Operating Loss (4,524,940) (1,802,433)
Other Income (Expense):    
Interest expense (161,205) (59,063)
Interest income 18,297 5,181
Net Operating Loss Before Income Tax Benefit (4,667,848) (1,856,315)
Income Tax Benefit 902,801
Net Loss $ (3,765,047) $ (1,856,315)
Net Loss Per Common Share - Basic and Diluted $ (0.10) $ (0.06)
Weighted Average Common Shares Used to Compute Net Loss Per Common Shares - Basic and Diluted 37,324,267 32,595,680